The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibition of melanogenesis by sodium 2-mercaptoethanesulfonate

  • Kim, Jeong-Hwan (R&D Unit, AmorePacific Corporation) ;
  • Oh, Chang-Taek (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Kwon, Tae-Rin (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Kim, Jong Hwan (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Bak, Dong-Ho (Department of Dermatology, Chung-Ang University College of Medicine) ;
  • Kim, Hyuk (R&D Unit, AmorePacific Corporation) ;
  • Park, Won-Seok (R&D Unit, AmorePacific Corporation) ;
  • Kim, Beom Joon (Department of Dermatology, Chung-Ang University College of Medicine)
  • Received : 2019.07.26
  • Accepted : 2020.01.14
  • Published : 2020.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Sodium 2-mercaptoethanesulfonate (mesna) is a protective agent that is widely used in medicine because of its antioxidant effects. Recently, reactive oxygen species (ROS) were shown to increase pigmentation. Thus, ROS scavengers and inhibitors of ROS production may suppress melanogenesis. Forkhead box-O3a (FoxO3a) is an antimelanogenic factor that mediates ROS-induced skin pigmentation. In this study, we aimed to investigate the whitening effect of mesna and the signaling mechanism mediating this effect. Human melanoma (MNT-1) cells were used in this study. mRNA and protein expression were measured by real-time quantitative PCR and Western blotting analysis to track changes in FoxO3a-related signals induced by mesna. An immunofluorescence assay was performed to determine the nuclear translocation of FoxO3a. When MNT-1 melanoma cells were treated with mesna, melanin production and secretion decreased. These effects were accompanied by increases in FoxO3a activation and nuclear translocation, resulting in downregulation of four master genes of melanogenesis: MITF, TYR, TRP1, and TRP2. We found that mesna, an antioxidant and radical scavenger, suppresses melanin production and may therefore be a useful agent for the clinical treatment of hyperpigmentation disorders.

Keywords

References

  1. Masaki H. Role of antioxidants in the skin: anti-aging effects. J Dermatol Sci. 2010;58:85-90. https://doi.org/10.1016/j.jdermsci.2010.03.003
  2. Meister A. Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem. 1994;269:9397-9400. https://doi.org/10.1016/S0021-9258(17)36891-6
  3. Villarama CD, Maibach HI. Glutathione as a depigmenting agent: an overview. Int J Cosmet Sci. 2005;27:147-153. https://doi.org/10.1111/j.1467-2494.2005.00235.x
  4. Kabasakal L, Sehirli AO, Cetinel S, Cikler E, Gedik N, Sener G. Mesna (2-mercaptoethane sulfonate) prevents ischemia/reperfusion induced renal oxidative damage in rats. Life Sci. 2004;75:2329-2340. https://doi.org/10.1016/j.lfs.2004.04.029
  5. Yilmaz ER, Kertmen H, Gurer B, Kanat MA, Arikok AT, Erguder BI, Hasturk AE, Ergil J, Sekerci Z. The protective effect of 2-mercaptoethane sulfonate (MESNA) against traumatic brain injury in rats. Acta Neurochir (Wien). 2013;155:141-149. https://doi.org/10.1007/s00701-012-1501-3
  6. Sakuma K, Ogawa M, Sugibayashi K, Yamada K, Yamamoto K. Relationship between tyrosinase inhibitory action and oxidationreduction potential of cosmetic whitening ingredients and phenol derivatives. Arch Pharm Res. 1999;22:335-339. https://doi.org/10.1007/BF02979054
  7. Kim J, Choi H, Cho EG, Lee TR. FoxO3a is an antimelanogenic factor that mediates antioxidant-induced depigmentation. J Invest Dermatol. 2014;134:1378-1388. https://doi.org/10.1038/jid.2013.510
  8. Wang H, Gao XD, Zhou GC, Cai L, Yao WB. In vitro and in vivo antioxidant activity of aqueous extract from Choerospondias axillaris fruit. Food Chem. 2008;106:888-895. https://doi.org/10.1016/j.foodchem.2007.05.068
  9. Chang TS, Ding HY, Tai SS, Wu CY. Mushroom tyrosinase inhibitory effects of isoflavones isolated from soygerm koji fermented with Aspergillus oryzae BCRC 32288. Food Chem. 2007;105:1430-1438. https://doi.org/10.1016/j.foodchem.2007.05.019
  10. Masamoto Y, Ando H, Murata Y, Shimoishi Y, Tada M, Takahata K. Mushroom tyrosinase inhibitory activity of esculetin isolated from seeds of Euphorbia lathyris L. Biosci Biotechnol Biochem. 2003;67:631-634. https://doi.org/10.1271/bbb.67.631
  11. Hosoi J, Abe E, Suda T, Kuroki T. Regulation of melanin synthesis of B16 mouse melanoma cells by 1 alpha, 25-dihydroxyvitamin D3 and retinoic acid. Cancer Res. 1985;45:1474-1478.
  12. Yu T, Ji J, Guo YL. MST1 activation by curcumin mediates JNK activation, Foxo3a nuclear translocation and apoptosis in melanoma cells. Biochem Biophys Res Commun. 2013;441:53-58. https://doi.org/10.1016/j.bbrc.2013.10.008
  13. Ura S, Masuyama N, Graves JD, Gotoh Y. MST1-JNK promotes apoptosis via caspase-dependent and independent pathways. Genes Cells. 2001;6:519-530. https://doi.org/10.1046/j.1365-2443.2001.00439.x
  14. Skinner R, Sharkey IM, Pearson AD, Craft AW. Ifosfamide, mesna, and nephrotoxicity in children. J Clin Oncol. 1993;11:173-190. https://doi.org/10.1200/JCO.1993.11.1.173
  15. Choi J, Oh S, Lee D, Oh HJ, Park JY, Lee SB, Lim DS. Mst1-FoxO signaling protects Naive T lymphocytes from cellular oxidative stress in mice. PLoS One. 2009;4:e8011. https://doi.org/10.1371/journal.pone.0008011
  16. Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol. 2011;65:689-697. https://doi.org/10.1016/j.jaad.2010.12.046
  17. Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14:359-376. https://doi.org/10.1007/s40257-013-0038-4
  18. Ros JR, Rodriguez-Lopez JN, Garcia-Canovas F. Effect of L-ascorbic acid on the monophenolase activity of tyrosinase. Biochem J. 1993; 295(Pt 1):309-312. https://doi.org/10.1042/bj2950309
  19. Huh CH, Seo KI, Park JY, Lim JG, Eun HC, Park KC. A randomized, double-blind, placebo-controlled trial of vitamin C iontophoresis in melasma. Dermatology. 2003;206:316-320. https://doi.org/10.1159/000069943

Cited by

  1. Effect of a Low Dose of Carvedilol on Cyclophosphamide-Induced Urinary Toxicity in Rats-A Comparison with Mesna vol.14, pp.12, 2020, https://doi.org/10.3390/ph14121237